GenomePooling™ method is sensitive and accurate
Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling method is...
View ArticlePopulation Genetics validates GenomePooling™ for cancer
Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling method is...
View ArticleNewLink Genetics Corporation Reports Second Quarter 2012 Financial Results
AMES, Iowa, Aug. 14, 2012 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (NLNK), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today reported...
View ArticleMelbourne researchers develop genetic test to predict risk of autism spectrum...
A team of Australian researchers, led by University of Melbourne has developed a genetic test that is able to predict the risk of developing Autism Spectrum Disorder, ASD. Lead researcher Professor...
View ArticleBoth genetics and environment influence peoples' choice of friends
London, November 1 (ANI): A team led by University of Colorado Boulder researchers has found that genetic similarities may help to explain why human birds of a feather flock together, but the full...
View ArticleFirst commercial gene therapy approved for Europe
A gene-therapy medicine has been given commercial approval in Europe for the first time. The treatment, Glybera, is designed to help those suffering from lipoprotein lipase deficiency — an inherited...
View ArticleInflammation may be a cause of plaque buildup in heart vessels
ScienceDaily (Dec. 2, 2012) Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists — including researchers at the...
View ArticleInterim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA
Seattle Genetics, Inc. (Nasdaq: SGEN) today presented interim results from a phase I clinical trial evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (PDA) at the...
View ArticleData From SGEN on Cancer Candidate
Seattle Genetics, Inc. (SGEN) recently presented interim results from a phase I study which is evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (:PDA). Seattle...
View ArticleReNeuron Group edges further in stem cell therapy research for stroke patients
LONDON (ShareCast) – ReNeuron Group received the green light to complete the final stages of first phase safety testing of its ReN001 stem cell therapy for disabled stroke patients in Scotland, the...
View ArticleInternational Stem Cell Corporation to Present at American Society of Gene...
CARLSBAD, CA–(Marketwired – May 1, 2013) – International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based...
View ArticleCritical Outcome Technologies Inc.: Promising Advance for Many Common Cancers
LONDON, ONTARIO–(Marketwired – June 11, 2013) -Critical Outcome Technologies Inc. (TSX VENTURE:COT) (“COTI” or the “Corporation”) announces positive results from experiments carried out with its lead...
View ArticleUrge to start smoking could be genetic, study says
Smokers are more likely to have children who also smoke, even if they quit before their child was born, MedPage Today reported. In a study published in the journal Pediatrics, researchers discovered...
View ArticleData on Cytori's Cell Therapy
Cytori Therapeutics, Inc. (CYTX) provided preliminary data from a study evaluating a potential treatment for scleroderma based on the companys cell therapy. The investigator-funded, open-label, pilot...
View ArticlePipeline Update at Alnylam – Analyst Blog
Alnylam Pharmaceuticals Inc. ( ALNY ) provided an update on its pipeline and its goals for the coming years. The company has progressed well with its ‘Alnylam 5×15′ program so far, and expects six to...
View ArticleNew Study Unleashes Potential Revolution in Stem Cell Research
In what is seen as a new era in stem cell biology, scientists have easily changed a differentiated cell back to an embryonic-like state by altering its environment. The new method does not involve any...
View ArticleInternational Stem Cell Corporation Announces Positive Interim Data From...
International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today announced positive data from the first interim...
View ArticleMenopausal hormone therapy may lower risk of B-cell non-Hodgkin lymphoma
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link...
View ArticleHormone therapy linked to lower non-Hodgkin lymphoma risk
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link...
View ArticleCochlear Implant Also Uses Gene Therapy to Improve Hearing
The electrodes in a cochlear implant can be used to direct gene therapy and regrow neurons. Growth factor: The cochlear nerve regenerates after gene therapy (top) versus the untreated cochlea from the...
View Article
More Pages to Explore .....